Digene

Digene Corporation is a molecular diagnostics company that develops, manufactures, and markets proprietary gene-based diagnostic tests for screening, monitoring, and diagnosing human diseases, with a focus on women's cancers and infectious diseases worldwide. The company primarily offers human papillomavirus (HPV) testing products, which are FDA-approved methods for detecting HPV, the leading cause of cervical cancer, providing repeatable and objective results. Its flagship product is the Digene HPV Test, an FDA-approved test for HPV, the primary cause of cervical cancer. The company is headquartered in Gaithersburg, Maryland, and was founded in 1984. In 1988, the first diagnostic test for human papillomavirus received FDA approval; this test was ViraPap, developed by Life Technologies, which was formed through the 1983 merger of GIBCO and Bethesda Research Laboratories.